Pharmacist‐initiated intervention trial in osteoarthritis: A multidisciplinary intervention for knee osteoarthritis
暂无分享,去创建一个
J. Esdaile | K. Grindrod | R. Tsuyuki | C. Marra | J. Cibere | M. Grubisic | L. Colley | Louise Gastonguay | Jamie M. Thomas | P. Embley | Karim M. Khan
[1] D. Hunter,et al. The epidemiology of osteoarthritis. , 2014, Best practice & research. Clinical rheumatology.
[2] Jennifer J. D'Souza,et al. Clinical Pharmacist Intervention and the Proportion of Diabetes Patients Attaining Prevention Objectives in a Multispecialty Medical Group , 2011, Journal of managed care pharmacy : JMCP.
[3] W. Jaeger,et al. Pharmacists' participation in research: a case of trying to find the time , 2010, The International journal of pharmacy practice.
[4] D. Hunter. Quality of osteoarthritis care for community-dwelling older adults. , 2010, Clinics in geriatric medicine.
[5] J. Kopec,et al. After patients are diagnosed with knee osteoarthritis, what do they do? , 2010, Arthritis care & research.
[6] J. Kopec,et al. Computerized Adaptive Testing in Back Pain: Validation of the CAT-5D-QOL , 2008, Spine.
[7] D. Feeny,et al. Validation of a prediction model to estimate health utilities index Mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the hip. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[8] Johanne Martel-Pelletier,et al. Cartilage in normal and osteoarthritis conditions. , 2008, Best practice & research. Clinical rheumatology.
[9] J. Esdaile,et al. Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. , 2007, Arthritis and rheumatism.
[10] Kathleen H Wilber,et al. Measuring the Quality of Care Provided to Community Dwelling Vulnerable Elders Dually Enrolled in Medicare and Medicaid , 2007, Medical care.
[11] David Feeny,et al. A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee. , 2007, The Journal of rheumatology.
[12] K. Jordan,et al. Treatment of knee pain in older adults in primary care: development of an evidence-based model of care. , 2006, Rheumatology.
[13] J. Sim,et al. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial , 2006, BMJ : British Medical Journal.
[14] David Feeny,et al. Comparing Short Form 6D, Standard Gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: Results from total hip arthroplasty patients , 2004, Quality of Life Research.
[15] J. Pencharz,et al. Measuring quality in arthritis care: the Arthritis Foundation's Quality Indicator set for osteoarthritis. , 2004, Arthritis & Rheumatism.
[16] Sally C Morton,et al. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. , 2004, Arthritis and rheumatism.
[17] D. Feeny,et al. Is the Health Utilities Index responsive in total hip arthroplasty patients? , 2003, Journal of clinical epidemiology.
[18] James G Wright,et al. Patient and provider factors related to comprehensive arthritis care in a community setting in Ontario, Canada. , 2003, The Journal of rheumatology.
[19] N. Bellamy. WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. , 2002, The Journal of rheumatology.
[20] G W Torrance,et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. , 2002, Osteoarthritis and cartilage.
[21] C. MacLean. Quality Indicators for the Management of Osteoarthritis in Vulnerable Elders , 2001, Annals of Internal Medicine.
[22] D L Riddle,et al. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network. , 1999, Physical therapy.
[23] N. Lane,et al. Management of osteoarthritis in the primary-care setting: an evidence-based approach to treatment. , 1997, The American journal of medicine.
[24] D. Dunlop,et al. The prevalence and impact of arthritis in older persons. , 1995, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[25] T. Schnitzer,et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. , 1995, Arthritis and rheumatism.
[26] Jennifer M. Hootman,et al. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation --- United States, 2007-2009. , 2010, MMWR. Morbidity and mortality weekly report.
[27] J. Esdaile,et al. Design of a Randomized Trial of a Multidisciplinary Intervention for Knee Osteoarthritis: Pharmacist Initiated Intervention Trial in Osteoarthritis (PhIT-OA): , 2008 .
[28] G W Torrance,et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results. , 2002, Osteoarthritis and cartilage.
[29] M. Karvonen,et al. The effects of training on heart rate; a longitudinal study. , 1957, Annales medicinae experimentalis et biologiae Fenniae.
[30] M. Abrahamowicz,et al. Health and Quality of Life Outcomes Assessment of Health-related Quality of Life in Arthritis: Conceptualization and Development of Five Item Banks Using Item Response Theory , 2022 .